It is now becoming generally recognized that microarray technology will be a fundamental tool used in future genomics research. As the technology becomes more widely accessible, larger numbers of ...

Most pharmaceuticals sold today have their origin in a biochemistry laboratory. Drug discovery has traditionally started with a biochemical pathway implicated in a pathophysiological process. An ...

Infinity Natural Resources, Inc. engages in the acquisition, exploration, and development of properties to produce oil, natural gas, and natural gas liquids from underground reservoirs in the United ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

Rupee vs Dollar: After a year marked by record lows, the Indian rupee may strengthen to 86 per US dollar by 2026, according to Bank of America Global Research. The projection challenges the widespread ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Amanda Jackson has expertise in personal finance, investing, and social services. She is a ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Find insight on venture-capital investments in climate-tech, Bentley Systems’ dual acquisition of Talon Aerolytics and Pointivo and more in the latest Market Talks covering Technology, Media and ...

USD/INR rallied over 5% in 2025 as capital outflow led to INR’s underperformance. The RBI's deliberate moderation of FX interventions provided a temporary relief. The INR faces a difficult road to ...

For 33 years, we've provided live analysis and coverage of stocks in play, market-moving events, news headlines, corporate earnings, broker rating changes, and more.